ProfileGDS4718 / 241037_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 43% 40% 44% 42% 28% 33% 48% 45% 41% 39% 43% 36% 32% 37% 41% 41% 35% 40% 45% 51% 35% 39% 39% 40% 35% 42% 32% 38% 38% 30% 34% 42% 42% 33% 36% 42% 41% 43% 40% 43% 35% 35% 33% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4655549
GSM549102patient 115, normal, homogenized [OPG study]5.1410743
GSM549104patient 119, normal, homogenized [OPG study]4.9890140
GSM549108patient 138, normal, homogenized [OPG study]5.2643644
GSM549119patient 077, normal, homogenized [OPG study]5.1218242
GSM549133patient 032, cancer, homogenized [OPG study]4.414728
GSM549139patient 042, cancer, homogenized [OPG study]4.6627933
GSM549099patient 107, normal, homogenized [OPG study]5.4302248
GSM549109patient 139, normal, homogenized [OPG study]5.2415545
GSM549110patient 046, normal, homogenized [OPG study]5.0576441
GSM549114patient 063, normal, homogenized [OPG study]4.8768139
GSM549122patient 082, normal, homogenized [OPG study]5.1364843
GSM549134patient 033, cancer, homogenized [OPG study]4.8116236
GSM549136patient 036, cancer, homogenized [OPG study]4.5613932
GSM549140patient 044, cancer, homogenized [OPG study]4.7893337
GSM549111patient 047, normal, homogenized [OPG study]5.0138941
GSM549113patient 057, normal, homogenized [OPG study]5.0067241
GSM549132patient 031, cancer, homogenized [OPG study]4.7334235
GSM549137patient 038, cancer, homogenized [OPG study]4.9664540
GSM549142patient 047, cancer, homogenized [OPG study]5.3825645
GSM549100patient 110, normal, homogenized [OPG study]5.5906851
GSM549107patient 135, normal, homogenized [OPG study]4.7435635
GSM549115patient 068, normal, homogenized [OPG study]4.8938239
GSM549116patient 072, normal, homogenized [OPG study]4.907939
GSM549120patient 078, normal, homogenized [OPG study]4.9783540
GSM549131patient 030, cancer, homogenized [OPG study]4.7084835
GSM549118patient 074, normal, homogenized [OPG study]5.1045242
GSM549129patient 027, cancer, homogenized [OPG study]4.6423732
GSM549123patient 088, normal, homogenized [OPG study]4.8707638
GSM549124patient 006, cancer, homogenized [OPG study]4.9296438
GSM549126patient 015, cancer, homogenized [OPG study]4.5312430
GSM549128patient 025, cancer, homogenized [OPG study]4.7050934
GSM549103patient 117, normal, homogenized [OPG study]5.1698342
GSM549117patient 073, normal, homogenized [OPG study]5.0713942
GSM549138patient 041, cancer, homogenized [OPG study]4.6297433
GSM549141patient 045, cancer, homogenized [OPG study]4.7396336
GSM549130patient 028, cancer, homogenized [OPG study]5.0858642
GSM549101patient 111, normal, homogenized [OPG study]5.0685241
GSM549105patient 128, normal, homogenized [OPG study]5.1543
GSM549106patient 134, normal, homogenized [OPG study]4.9432240
GSM549112patient 048, normal, homogenized [OPG study]5.1039243
GSM549125patient 011, cancer, homogenized [OPG study]4.7864535
GSM549127patient 024, cancer, homogenized [OPG study]4.768935
GSM549135patient 035, cancer, homogenized [OPG study]4.6010633